Related Experiment Video
Updated: Apr 13, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Type 1 diabetes pathogenesis - Prevention???
C S Muralidhara Krishna1, S Srikanta2
1Faculty, Bangalore Medical College and Research Institute, Bangalore, India; Honorary Consultant.
Type 1 diabetes involves autoimmunity, genetics, and environment, leading to beta-cell destruction. Early detection via islet cell autoantibodies and potential therapeutic interruption offer hope for preventing and curing this autoimmune disease.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1 diabetes (T1DM) pathogenesis is complex, involving autoimmunity, genetic predisposition, and environmental triggers.
- Autoimmunity against pancreatic islet cells causes progressive beta-cell destruction, leading to insulin-dependent diabetes mellitus (IDDM).
- Islet cell autoantibodies (ICAb) are key biomarkers for T1DM, aiding in early prediction and understanding disease progression.
Purpose of the Study:
- To explore the multifaceted pathogenesis of type 1 diabetes, focusing on autoimmunity and environmental factors.
- To highlight the diagnostic and prognostic significance of islet cell autoantibodies in T1DM.
- To discuss potential therapeutic strategies targeting autoimmunity and beta-cell preservation for T1DM reversal.
Main Methods:
- Review of current literature on T1DM pathogenesis, autoimmunity, and environmental influences.
- Analysis of the role of islet cell autoantibodies in disease prediction and monitoring.
- Examination of emerging therapeutic targets and prevention strategies for T1DM.
Main Results:
- Islet cell autoantibodies are crucial for identifying individuals at risk and monitoring disease.
- Recent findings suggest non-uniform beta-cell destruction, offering hope for therapeutic intervention.
- Environmental factors like congenital rubella, viruses, gluten, and cow's milk are implicated, while gut flora, helminths, and Vitamin D may be protective.
- Anti-CD3 therapies (teplizumab, otelixizumab) have shown potential in preserving C-peptide levels.
Conclusions:
- Understanding T1DM pathogenesis, including autoimmunity and environmental factors, is key to developing effective prevention and treatment strategies.
- Early detection using islet cell autoantibodies and targeted therapies can preserve beta-cell function and potentially reverse T1DM.
- Further research is needed to address autoimmune memory, re-establish self-tolerance, and elucidate disease initiation mechanisms.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

